Myla Lai-Goldman
Signal active
Venture Partner
Bio
Myla Lai-Goldman is a Co-Founder and Chair at GeneCentric Therapeutics and a Venture Partner at Hatteras Venture Partners. Myla was an Executive VP, CMO, and CSO at Labcorp. She attended Columbia University Vagelos College of Physicians and Surgeons and the University of Pennsylvania,
Location
South Burlington, Vermont, United States, North America
Social
Primary Organization
Hatteras Venture Partners
Founded
2000
Investment
113
Lead investment
40
Exits
25
Employees
11-50
Industry
Financial Services, Venture Capital, Medical
Jobs history
4
Labcorp Drug Development
Executive VP, CMO and CSO
1990 - 2008
Biocogniv
Advisor
Invalid date - Current
GeneCentric Therapeutics
Co-Founder and Chair
2021 - Current
Personalized Science, LLC
Managing Partner
2009 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Myla Lai-Goldman is the Venture Partner at Hatteras Venture Partners, based in United States, North America. With a background in Financial Services, Myla Lai-Goldman has a rich history of leadership and innovation. Myla Lai-Goldman studied BA Biology @ University of Pennsylvania. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
Jonathan Hirsch
Chief Strategy and Growth Officer
Leo Grady
Founder and CEO
John Abele
Board Member
Investment portfolio
Myla Lai-Goldman has made 1 investments. Their Latest investment was Seed Round - Biocogniv on Aug 31, 2020
Number of investment
1
Number of exits
0
Personal investment
1
| Annouced Date | Organization Name | Funding Round | Money Raised |
|---|---|---|---|
| Aug 31, 2020 | Biocogniv | Seed Round - Biocogniv | 6.0M |
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.